Nuclear Medicine & Radiation Therapy

Mercedes Iñarrairaegui

Publications

• Special Issue Article
  Radioembolization for Hepatocellular Carcinoma: Evidence-Based Answers to Frequently Asked Questions
  Author(s): Bruno Sangro and Mercedes IñarrairaeguiBruno Sangro and Mercedes Iñarrairaegui
  
  Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality. Radioembolization is a form of selective internal radiation therapy that is increasingly used to treat patients with HCC, particularly those with more advanced disease. This review will try to answer some of the most frequently asked questions regarding the use of radioembolization to treat HCC patients and provide supporting evidence. Rather than a new form of transarterial chemoembolization (TACE), radioembolization is a form of brachytherapy that has a highly localized effect on liver tumors. The two devices that are available (glass and resin microspheres) are similar in size (25 to 35 microns), but differ in the amount of isotope loaded onto each microsphere and the number of spheres injected in a single treatment. Despite this, the evidence seems to indicate that the antitumor effect and s.. Read More»
  DOI: 10.4172/2155-9619.1000110

  Abstract PDF